Literature DB >> 11277991

Low intensity spinal cord stimulation may induce cutaneous vasodilation via CGRP release.

S Tanaka1, K W Barron, M J Chandler, B Linderoth, R D Foreman.   

Abstract

This study examined whether spinal cord stimulation (SCS) at intensities below motor threshold (MT) produces cutaneous vasodilation through sympathetic inhibition and/or antidromic activation of sensory fibers. SCS was applied to anesthetized rats with stimulus parameters used clinically, i.e. 50 Hz, 0.2 ms and stimulus intensities at 30, 60 or 90% of MT. SCS-induced vasodilation was not attenuated by hexamethonium, an autonomic ganglion blocking agent, but was abolished by CGRP-(8-37), an antagonist of the calcitonin gene-related peptide (CGRP) receptor. We concluded that SCS-induced vasodilation under the conditions of this study was mediated by peripheral release of CGRP via antidromic activation of sensory fibers.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11277991     DOI: 10.1016/s0006-8993(01)02144-8

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Low-level laser therapy and light-emitting diode effects in the secretion of neuropeptides SP and CGRP in rat skin.

Authors:  Bernardo Hochman; Carlos E Pinfildi; Michele A Nishioka; Fabianne Furtado; Silvilena Bonatti; Paola K P Monteiro; Arainy S Antunes; Paulo R Quieregatto; Richard E Liebano; Gerson Chadi; Lydia Masako Ferreira
Journal:  Lasers Med Sci       Date:  2013-12-15       Impact factor: 3.161

2.  Spinal cord stimulation ameliorates detrusor over-activity and visceromotor pain responses in rats with cystitis.

Authors:  Huiyi H Chang; Jih-Chao Yeh; Jackie Mao; David A Ginsberg; Gamal Ghoniem; Larissa V Rodriguez
Journal:  Neurourol Urodyn       Date:  2018-11-09       Impact factor: 2.696

3.  Spinal cord stimulation modulates intraspinal colorectal visceroreceptive transmission in rats.

Authors:  C Qin; R T Lehew; K A Khan; G M Wienecke; R D Foreman
Journal:  Neurosci Res       Date:  2007-02-04       Impact factor: 3.304

4.  Thoracic spinal cord stimulation improves functional status and relieves symptoms in patients with refractory angina pectoris: the first placebo-controlled randomised study.

Authors:  Stephan Eddicks; Klaus Maier-Hauff; Michael Schenk; Andreas Müller; Gert Baumann; Heinz Theres
Journal:  Heart       Date:  2007-01-19       Impact factor: 5.994

5.  Extracellular signal-regulated kinase (ERK) and protein kinase B (AKT) pathways involved in spinal cord stimulation (SCS)-induced vasodilation.

Authors:  Mingyuan Wu; Naoka Komori; Chao Qin; Jay P Farber; Bengt Linderoth; Robert D Foreman
Journal:  Brain Res       Date:  2008-01-12       Impact factor: 3.252

6.  Roles of dorsal column pathway and transient receptor potential vanilloid type 1 in augmentation of cerebral blood flow by upper cervical spinal cord stimulation in rats.

Authors:  X Yang; J P Farber; M Wu; R D Foreman; C Qin
Journal:  Neuroscience       Date:  2008-01-12       Impact factor: 3.590

Review 7.  Putative mechanisms behind effects of spinal cord stimulation on vascular diseases: a review of experimental studies.

Authors:  Mingyuan Wu; Bengt Linderoth; Robert D Foreman
Journal:  Auton Neurosci       Date:  2008-02-29       Impact factor: 3.145

8.  Roles of peripheral terminals of transient receptor potential vanilloid-1 containing sensory fibers in spinal cord stimulation-induced peripheral vasodilation.

Authors:  Mingyuan Wu; Naoka Komori; Chao Qin; Jay P Farber; Bengt Linderoth; Robert D Foreman
Journal:  Brain Res       Date:  2007-04-30       Impact factor: 3.252

9.  Normalization of Blood Pressure With Spinal Cord Epidural Stimulation After Severe Spinal Cord Injury.

Authors:  Susan J Harkema; Siqi Wang; Claudia A Angeli; Yangsheng Chen; Maxwell Boakye; Beatrice Ugiliweneza; Glenn A Hirsch
Journal:  Front Hum Neurosci       Date:  2018-03-08       Impact factor: 3.169

10.  Sodium channel Nav1.7 in vascular myocytes, endothelium, and innervating axons in human skin.

Authors:  Frank L Rice; Phillip J Albrecht; James P Wymer; Joel A Black; Ingemar Sj Merkies; Catharina G Faber; Stephen G Waxman
Journal:  Mol Pain       Date:  2015-05-09       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.